GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immuno-Biological Laboratories Co Ltd (TSE:4570) » Definitions » 3-Year EPS without NRI Growth Rate

Immuno-Biological Laboratories Co (TSE:4570) 3-Year EPS without NRI Growth Rate : 0.00% (As of Sep. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Immuno-Biological Laboratories Co 3-Year EPS without NRI Growth Rate?

Immuno-Biological Laboratories Co's EPS without NRI for the three months ended in Sep. 2024 was 円0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Immuno-Biological Laboratories Co was 36.20% per year. The lowest was -210.50% per year. And the median was -15.00% per year.


Competitive Comparison of Immuno-Biological Laboratories Co's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, Immuno-Biological Laboratories Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immuno-Biological Laboratories Co's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immuno-Biological Laboratories Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Immuno-Biological Laboratories Co's 3-Year EPS without NRI Growth Rate falls into.


;
;

Immuno-Biological Laboratories Co 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Immuno-Biological Laboratories Co  (TSE:4570) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Immuno-Biological Laboratories Co 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Immuno-Biological Laboratories Co's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Immuno-Biological Laboratories Co Business Description

Traded in Other Exchanges
N/A
Address
1091-1 Naka Aza-Higashida, Gunma, Fujioka, JPN, 375-0005
Immuno-Biological Laboratories Co Ltd focuses on research and development. It researches, develops, manufacture and supplies various immunological research reagents, and customized services. It is engaged in research and development of materials used in diagnostic products and valuable seeds and technology for protein production using transgenic silkworm cocoons, which make it possible to create valuable proteins as well as antibodies. It works on clinical reagents for cancer research. Its research scientists are producing inflammatory cytokines, growth factors & antibodies for use against these cancers.

Immuno-Biological Laboratories Co Headlines

No Headlines